Tenet Healthcare faces cautious outlook with Q2 earnings pressured by fewer patient days but boosted by outpatient growth.

Tenet Healthcare Corporation's stock price targets have declined, reflecting analyst caution amid upcoming Q2 earnings. The company may experience pressure from lower patient days, but this could be offset by higher revenue per patient and growth in its Ambulatory Care division. Industry trends show an improving earnings forecast for hospitals, suggesting Tenet might be undervalued. Investors should watch the Q2 report closely for clearer direction.